Mount Sinai Medical Center, New York, NY
Copyright 2016, American College of Chest Physicians. All Rights Reserved.
SESSION TITLE: Pulmonary Rehabilitation
SESSION TYPE: Original Investigation Poster
PRESENTED ON: Wednesday, October 26, 2016 at 01:30 PM - 02:30 PM
PURPOSE: Studies evaluating the outcome of patients receiving tracheostomy are scarce and conflicting. Some reported patients who receive tracheostomy had improved survival, while others showed that tracheostomy has no positive impact on overall survival. These discrepancies explain the lack of consensus on outcomes that can guide families to make a fully informed decision
METHODS: Retrospective chart review of all patients who received a new tracheostomy during surgical intensive care unit stay (SICU) of a tertiary academic medical center between January 1, 2012 and July 1st, 2015. Thirty day survival post SICU was determined.
RESULTS: A total of 173 patients received tracheostomy in the study period. 66 (38.2%) patients died within 30 days of hospital discharge. Average ICU length of stay (LOS) 32.6 days and average hospital LOS 72.2 days. 101 of the patients had percutaneous tracheostomy (62.4%), mortality rate for percutaneous technique 38.6 %, vs. open 37.5 % (p < 0.05). There have been no mortality related to the procedure.
CONCLUSIONS: Patients who required tracheostomy during their SICU stay had high 30 day mortality, prolonged ICU and hospital stay. Procedure technique had no influence on outcome. Incorporating this outcome data into the goals of care discussion prior to the procedure is critical in guiding families to obtain a well informed decision.
CLINICAL IMPLICATIONS: This data demonstrates high mortality rate and long ICU and hospital stay amongst patients who receive tracheostomy. This objective analysis could be a reference to improve patient selection and tracheostomy utilization particularly towards the end of life.
DISCLOSURE: The following authors have nothing to disclose: Catherine Allen, Adel Bassily-Marcus, Taylor Moran-Gates, Talia Helman, Anthony Manasia, John Oropello, Roopa Kohli-Seth
No Product/Research Disclosure Information
Become a CHEST member and receive a FREE subscription as a benefit of membership.
Individuals can purchase this article on ScienceDirect.
Individuals can purchase a subscription to the journal.
Individuals can purchase a subscription to the journal or buy individual articles.
Learn more about membership or Purchase a Full Subscription.
Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited:
Customize your page view by dragging & repositioning the boxes below.
Enter your username and email address. We'll send you a reminder to the email address on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.